- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript4 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Q2 2023 Nykode Therapeutics ASA Earnings Call Transcript
Hello, and welcome to the Nykode Therapeutics Q2-2023 financial results presentation. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the floor over to your host, CEO, Michael Engsig. Please go ahead, sir.
Thank you very much, and welcome to -- everybody joining in for this call. We are once again very happy and pleased to be updating you on what's going on in Nykode Therapeutics over the last quarter. Just for formalities, again, as usual, we assume you're all familiar with our forward-looking statements. And on that note, we'll move forward.
I'm pleased to be joined here today by Agnete Fredriksen, our Co-Founder and Chief Business Officer, as well as Harald Gurvin, our Chief Financial Officer. And together, we'll take you through an update on our business activities and R&D program, as well as the financial results.
If we look at the highlights in Q2 for the 2023 was yes, a very busy and successful and rewarding quarter for us. Most
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)